Currently holds positions in Abbvie Inc and Aptinyx Inc
Position | Company | Period |
---|---|---|
Executive Vice President, Chief Strategy Officer | Abbvie Inc | Dec. 1, 2015 - |
Independent Director | Aptinyx Inc | May 6, 2019 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-05-09 |
ACELYRIN Inc
(SLRN)
|
B Purchase |
50,000
+inf%
18.00900,000 USD |
50,000 +inf% | 18.00 | 900,000 USD | |
2022-05-18 | 2022-05-16 |
Abbvie Inc
(ABBV)
|
S Sale |
83,960
-83.5%
155.0013,013,800 USD |
83,960 -83.5% | 155.00 | 13,013,800 USD | |
2022-03-02 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.6%
149.3814,938 USD |
100 -0.6% | 149.38 | 14,938 USD | |
2022-03-02 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
4,000
-19.3%
148.71594,824 USD |
4,000 -19.3% | 148.71 | 594,824 USD | |
2022-03-02 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
5,167
-20.0%
147.60762,657 USD |
5,167 -20.0% | 147.60 | 762,657 USD | |
2022-03-02 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
15,733
-37.8%
146.812,309,770 USD |
15,733 -37.8% | 146.81 | 2,309,770 USD | |
2022-03-01 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
1,101
-2.6%
149.14164,208 USD |
1,101 -2.6% | 149.14 | 164,208 USD | |
2022-03-01 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
8,303
-16.3%
148.621,234,012 USD |
8,303 -16.3% | 148.62 | 1,234,012 USD | |
2022-03-01 | 2022-03-01 |
Abbvie Inc
(ABBV)
|
S Sale |
5,596
-9.9%
147.54825,616 USD |
5,596 -9.9% | 147.54 | 825,616 USD | |
2020-11-24 | 2020-11-20 |
Abbvie Inc
(ABBV)
|
S Sale |
33,100
-62.3%
99.493,293,119 USD |
33,100 -62.3% | 99.49 | 3,293,119 USD | |
2020-11-24 | 2020-11-20 |
Abbvie Inc
(ABBV)
|
S Sale |
6,900
-11.5%
98.83681,927 USD |
6,900 -11.5% | 98.83 | 681,927 USD | |
2020-01-14 | 2020-01-10 |
Aptinyx Inc
(APTX)
|
B Purchase |
25,000
+25.0%
3.0075,000 USD |
25,000 +25.0% | 3.00 | 75,000 USD | |
2019-07-31 | 2019-07-29 |
Abbvie Inc
(ABBV)
|
B Purchase |
30,000
+65.6%
67.282,018,385 USD |
30,000 +65.6% | 67.28 | 2,018,385 USD | |
2019-05-09 | 2019-05-08 |
Aptinyx Inc
(APTX)
|
B Purchase |
96,580
+2824.0%
3.86372,799 USD |
96,580 +2824.0% | 3.86 | 372,799 USD | |
2019-05-09 | 2019-05-07 |
Aptinyx Inc
(APTX)
|
B Purchase |
3,420
+inf%
3.7512,825 USD |
3,420 +inf% | 3.75 | 12,825 USD | |
2018-11-30 | 2018-11-29 |
Abbvie Inc
(ABBV)
|
S Sale |
42,450
-58.3%
90.103,824,940 USD |
42,450 -58.3% | 90.10 | 3,824,940 USD | |
2017-10-31 | 2017-10-30 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.2%
92.029,202 USD |
100 -0.2% | 92.02 | 9,202 USD | |
2017-10-31 | 2017-10-30 |
Abbvie Inc
(ABBV)
|
S Sale |
4,482
-6.4%
91.22408,849 USD |
4,482 -6.4% | 91.22 | 408,849 USD | |
2017-10-31 | 2017-10-30 |
Abbvie Inc
(ABBV)
|
S Sale |
11,568
-14.2%
90.491,046,814 USD |
11,568 -14.2% | 90.49 | 1,046,814 USD | |
2017-10-31 | 2017-10-30 |
Abbvie Inc
(ABBV)
|
S Sale |
2,150
-2.6%
89.38192,172 USD |
2,150 -2.6% | 89.38 | 192,172 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.347,034 USD |
100 -0.1% | 70.34 | 7,034 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.297,029 USD |
100 -0.1% | 70.29 | 7,029 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
200
-0.2%
70.2514,050 USD |
200 -0.2% | 70.25 | 14,050 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
600
-0.7%
70.2342,138 USD |
600 -0.7% | 70.23 | 42,138 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
400
-0.5%
70.2228,088 USD |
400 -0.5% | 70.22 | 28,088 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
700
-0.8%
70.2149,147 USD |
700 -0.8% | 70.21 | 49,147 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
500
-0.6%
70.2035,100 USD |
500 -0.6% | 70.20 | 35,100 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
1,200
-1.4%
70.1984,228 USD |
1,200 -1.4% | 70.19 | 84,228 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
300
-0.3%
70.1921,056 USD |
300 -0.3% | 70.19 | 21,056 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
500
-0.6%
70.1835,090 USD |
500 -0.6% | 70.18 | 35,090 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
200
-0.2%
70.1814,035 USD |
200 -0.2% | 70.18 | 14,035 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
400
-0.4%
70.1728,068 USD |
400 -0.4% | 70.17 | 28,068 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
600
-0.7%
70.1642,096 USD |
600 -0.7% | 70.16 | 42,096 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.157,015 USD |
100 -0.1% | 70.15 | 7,015 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.147,014 USD |
100 -0.1% | 70.14 | 7,014 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
800
-0.9%
70.1356,104 USD |
800 -0.9% | 70.13 | 56,104 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
700
-0.8%
70.1249,084 USD |
700 -0.8% | 70.12 | 49,084 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
200
-0.2%
70.1214,023 USD |
200 -0.2% | 70.12 | 14,023 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
1,000
-1.1%
70.1170,110 USD |
1,000 -1.1% | 70.11 | 70,110 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
400
-0.4%
70.1028,040 USD |
400 -0.4% | 70.10 | 28,040 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.097,009 USD |
100 -0.1% | 70.09 | 7,009 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.087,008 USD |
100 -0.1% | 70.08 | 7,008 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
400
-0.4%
70.0728,028 USD |
400 -0.4% | 70.07 | 28,028 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.057,005 USD |
100 -0.1% | 70.05 | 7,005 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
300
-0.3%
70.0421,012 USD |
300 -0.3% | 70.04 | 21,012 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
600
-0.6%
70.0242,012 USD |
600 -0.6% | 70.02 | 42,012 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
1,537
-1.6%
70.01107,605 USD |
1,537 -1.6% | 70.01 | 107,605 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.017,001 USD |
100 -0.1% | 70.01 | 7,001 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
5,663
-5.6%
70.00396,410 USD |
5,663 -5.6% | 70.00 | 396,410 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
200
-0.2%
70.4514,090 USD |
200 -0.2% | 70.45 | 14,090 USD | |
2017-08-02 | 2017-07-31 |
Abbvie Inc
(ABBV)
|
S Sale |
100
-0.1%
70.377,037 USD |
100 -0.1% | 70.37 | 7,037 USD |